[go: up one dir, main page]

MD3644F1 - Preparation for algodismenorrhea treatment - Google Patents

Preparation for algodismenorrhea treatment

Info

Publication number
MD3644F1
MD3644F1 MDA20080075A MD20080075A MD3644F1 MD 3644 F1 MD3644 F1 MD 3644F1 MD A20080075 A MDA20080075 A MD A20080075A MD 20080075 A MD20080075 A MD 20080075A MD 3644 F1 MD3644 F1 MD 3644F1
Authority
MD
Moldova
Prior art keywords
preparation
algodismenorrhea
treatment
suppository
invention consists
Prior art date
Application number
MDA20080075A
Other languages
Romanian (ro)
Other versions
MD3644G2 (en
Inventor
Victor GHICAVII
Refael Barkan
Original Assignee
Refael Barkan
Victor GHICAVII
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Refael Barkan, Victor GHICAVII filed Critical Refael Barkan
Priority to MDA20080075A priority Critical patent/MD3644G2/en
Publication of MD3644F1 publication Critical patent/MD3644F1/en
Priority to CN200880123695.5A priority patent/CN101917848B/en
Priority to PCT/IL2008/001466 priority patent/WO2009060451A2/en
Priority to EP08846478.9A priority patent/EP2219447B1/en
Priority to EA201000732A priority patent/EA030035B1/en
Priority to US12/741,759 priority patent/US20100305210A1/en
Publication of MD3644G2 publication Critical patent/MD3644G2/en
Priority to IL205535A priority patent/IL205535A/en
Priority to US16/944,137 priority patent/US12011423B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention refers to medicine, in particular to pharmacology and gynecology. Summary of the invention consists in using diethyl phosphate-S-ethyl isothiouronium as analgesic preparation for treatment of primary and secondary algodismenorrhea. The result of the invention consists in that at the local use of the given medicinal preparation in the form of suppository in 95à100% of cases it is attained disappearance of the pain syndrome after the second applied suppository.
MDA20080075A 2007-11-06 2008-03-17 Preparation for algodismenorrhea treatment MD3644G2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MDA20080075A MD3644G2 (en) 2008-03-17 2008-03-17 Preparation for algodismenorrhea treatment
CN200880123695.5A CN101917848B (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
PCT/IL2008/001466 WO2009060451A2 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EP08846478.9A EP2219447B1 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EA201000732A EA030035B1 (en) 2007-11-06 2008-11-06 Use of s-ethylisothiouronium diethylphosphate for the manufacture of a medicament for treating a uterine hypercontractility disorder
US12/741,759 US20100305210A1 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating abnormal uterine bleeding disorders
IL205535A IL205535A (en) 2007-11-06 2010-05-04 S- alkylisothiouronium derivatives for treating uterine hypercontractility disorders
US16/944,137 US12011423B2 (en) 2007-11-06 2020-07-30 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080075A MD3644G2 (en) 2008-03-17 2008-03-17 Preparation for algodismenorrhea treatment

Publications (2)

Publication Number Publication Date
MD3644F1 true MD3644F1 (en) 2008-07-31
MD3644G2 MD3644G2 (en) 2009-02-28

Family

ID=39684058

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080075A MD3644G2 (en) 2007-11-06 2008-03-17 Preparation for algodismenorrhea treatment

Country Status (1)

Country Link
MD (1) MD3644G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4004C2 (en) * 2009-10-16 2010-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antiinflammatory agent in the hemorrhagic shock

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD586C2 (en) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedy antihypotensif "Difetur"
MD1223C2 (en) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Application of S-methyl isothiouronium dimethyl phosphate as a vasoconstrictor compound and pharmaceutical preparation on base thereof
MD2228G2 (en) * 2003-01-21 2004-02-29 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD2491G2 (en) * 2004-02-10 2005-01-31 Виктор ГИКАВЫЙ Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Also Published As

Publication number Publication date
MD3644G2 (en) 2009-02-28

Similar Documents

Publication Publication Date Title
MX2009006823A (en) Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof.
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
MX2011011950A (en) Sublingual dexmedetomidine compositions and methods of use thereof.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX337575B (en) Sulphone compounds for use in the treatment of obesity.
JO3776B1 (en) PHARMACEUTICAL COMBINATIONS of a CDK4/6 inhibitor and B-Raf inhibitor
AU2008267058A8 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
WO2011026125A3 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
MX2010009623A (en) 1-benzyl-3-hydroxymethylindazoiî¹e derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1.
MX2012007933A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof.
MX2010001449A (en) Bupropion hydrobromide and therapeutic applications.
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
MX2010009625A (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40.
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
PH12013500857A1 (en) Methods and compositions for treating hiv-associated diarrhea
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MXPA06013133A (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction.
NZ580975A (en) Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
MD3644F1 (en) Preparation for algodismenorrhea treatment
MX2010011193A (en) Liquid pharmaceutical composition for pain treatment and prevention.
PH12015500070B1 (en) Pediatric oral liquid compositions containing nepadutant
GB201312583D0 (en) Combination and composition for treating obesity
WO2009075838A3 (en) Treatment of menorrhagia with aromatase inhibitor

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees